These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29441189)

  • 141. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 142. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series.
    Ghaziuddin N; Hendriks M; Patel P; Wachtel LE; Dhossche DM
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):359-365. PubMed ID: 28398818
    [TBL] [Abstract][Full Text] [Related]  

  • 146. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 147. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome].
    Hirjak D; Sartorius A; Kubera KM; Wolf RC
    Nervenarzt; 2019 Jan; 90(1):12-24. PubMed ID: 30128733
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Neuroleptic malignant syndrome.
    Rampertaap MP
    South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 151. [Electroconvulsive therapy: 80 years of use in psychiatry].
    Kaliora SC; Zervas IM; Papadimitriou GN
    Psychiatriki; 2018; 29(4):291-302. PubMed ID: 30814039
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 153. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 154. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S
    AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Neuroleptic malignant syndrome: an overview.
    Persing JS
    S D J Med; 1994 Feb; 47(2):51-5. PubMed ID: 8140409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 8.